IBL creates clinical vaccine batches for use in human trials and contracts with a manufacturer of vaccines. They set up a small-scale manufacturing facility with the ability to produce liquid or lyophilized vaccines at a volume suitable for Phase III clinical trials. They create, manufacture, and distribute instant point-of-care screening and